Popular search terms:
Search Results
61 results found-
Contact CSL Limited corporate communications team for products and investor relations.
https://www.csl.com/news/newsroom -
Update on The University of Queensland COVID-19 vaccine
https://www.csl.com/news/2020/20201211-update-on-the-university-of-queensland-covid-19-vaccine -
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
https://www.csl.com/ -
CSL is working around the world with academia, industry and governments to combat the novel coronavirus COVID-19
https://www.csl.com/news/2020/covid-19-csl-facts -
CSL continues to provide medicines to patients around the world.
https://www.csl.com/news/2020/covid-19-update -
Confirms Australian manufacturing schedule is on-track to produce Oxford/AstraZeneca COVID-19 vaccine candidate
https://www.csl.com/news/2020/20201108-csl-commences-manufacturing-of-university-of-oxford-astrazeneca-vaccine-candidate -
Forbes Recognizes Global Biotechnology Leader for Fourth Straight Year
https://www.csl.com/news/2020/20201029-csl-named-as-one-of-the-worlds-best-employers -
CSL’s Broad Response to COVID-19 and Advancements Across the Company’s Strategic Scientific Platforms are the Focus of Annual R&D Day
https://www.csl.com/news/2020/20201020-annual-research-and-development-day-briefing -
CSL Behring agrees to acquire novel late-stage gene therapy candidate for Hemophilia B patients from uniQure
https://www.csl.com/news/2020/20201015-2021-csl-centenary-fellowships-announced